CBD Nutraceuticals Market - By Product Type, By Application, By Distribution Channel– Growth Forecast, 2025 - 2034

CBD Nutraceuticals Market Size

The global CBD nutraceuticals market was valued at USD 10.7 billion in 2024 and is projected to grow at a CAGR of over 17.5% from 2025 to 2034. The market is driven by the rising awareness about the benefits of cannabidiol in managing chronic issues and other wellness concerns.
 

According to the report by Brightfield Group, sales of CBD products in the US were around USD 5.3 billion in 2021 and are expected to grow to nearly USD 16 billion by 2026. This strong growth shows the rising demand and popularity of CBD nutraceuticals for in the market.
 

Consumer spending on clean label, plant-based, health-enhancing, and innovative products aimed at chronic condition management greatly drives this market. AI personalization tools have also significantly impacted customer interaction and product recommendations. This, along with the shift toward sustainable organic CBD farming, shows changes in consumer preferences. These sustainable and low-cost extraction farming methods are beneficial for both new and existing market manufacturers, leading to wider industry growth. Also, wellness brands, researchers, and regulatory bodies are actively developing standardized and safer CBD products, driving the market growth.
 

The market of CBD nutraceuticals includes dietary supplements and fortified functional foods and beverages with CBD derived from hemp or cannabis plants. These products focus on health and wellness applications, including stress management, pain relief, and sleep improvement.
 

CBD Nutraceuticals Market Trends

The market is rapidly expanding due to increasing consumer demand for natural health supplements, growing research on CBD’s benefits, and evolving regulatory landscapes.
 

• The increasing chronic diseases such as, arthritis, diabetes, and other cardiovascular issues is driving the market. According to the CDC, approximately 38.4 million Americans, or nearly 11.6% of the total population, are suffering from diabetes, thereby reflecting the need for CBD Nutraceuticals products for management of these conditions.
   
• Managing chronic pain using CBD products is significantly easier due to the anti-inflammatory and analgesic features of CBD. Moreover, CBD helps in reducing anxiety and depression, which tackles other aspects of mental health. As per WHO estimates, more than 1 billion people across the globe are suffering from mental disorders, anxiety, and depression. This proves the need for CBD products in resolving the mental health crisis across the globe.
   
• CBD acceptance is rising with the growing trend of herbal and plant-based medicine, which also drives innovation. The launch of new medications in different forms such as capsules, tinctures, gummies, and infused drinks is contributing towards market expansion.
   
• Furthermore, as the more people become aware of CBD’s benefits, medical practitioners are increasingly recommending it. This is also fueling the growth of the market. Favorable regulatory shifts coupled with increased innovation in the sector is further driving the adoption of nutraceuticals among medical practitioners.
   

CBD Nutraceuticals Market Analysis

Based on the product type, the market is segmented into CBD oils, CBD tinctures, CBD capsules and softgels, CBD gummies and chews, and other product types. The CBD oils segment dominated the market with USD 2.3 billion in 2021, USD 2.6 billion in 2022 and USD 3 billion in 2023.
 

• Cannabidiol oil are popular for their efficiency and ease of use in the current market. These oils are beneficial because they are administered through the sublingual route, which greatly improves their absorption and provides beneficial effects. These oils are formulated in low to high ranges of CBD concentration to meet consumer needs in reducing stress through chronic pain management.
   
• This segment is expected to grow further because of new knowledge about cannabidiol as a natural alternative to medicines. Product innovation, such as flavored oils and combination products with vitamins or essential oils, has increased their appeal. Additionally, improved regulations and growing global interest in wellness products drive the market share of these oils further, especially with CBD.

Based on application, the CBD nutraceuticals market is divided into pain management, anxiety and stress reduction, sleep disorders, mental health, and other applications. The pain management segment accounted for significant market share of 35.5% in 2024.
 

• Pain management is the leading segment due to multiple factors, such as the rising number of people suffering from chronic pain diseases including arthritis, neuropathy, and fibromyalgia.
   
• CBD's anti-inflammatory and analgesic effects have increased its popularity as a substitute for traditional pain medications, which are often accompanied by negative side effects. Its non-addictive property has also gained acceptance from many healthcare providers and patients.
   
• CBD has also proven to help with reducing inflammation and nerve pain. The demand for products intended for pain relief is on the rise. The increase in pain-related illnesses, as well as the developing specialized capsule and cream formulations for pain management are some of the factors driving the growth in this segment.
   

Based on distribution channel, the CBD nutraceuticals market is divided into retail stores, pharmacies, e-commerce, and other distribution channels. The retail stores segment dominated the market in 2024 and is expected to reach USD 20.1 billion within the forecast period.  
 

• Retail stores serve as the most widespread distribution channel for CBD nutraceutical products, which gives consumers immediate access to a wide selection of CBD products.
   
• Retail stores help consumers by providing them guidance on product knowledge and also suggest appropriate products for their needs.
   
• Physical stores are convenient for customers who want to confirm the legitimacy of a product.
   
• In addition, special marketing activities such as advertising and consumer sampling in retail outlets encourage customers to visit these outlets, thereby strengthening retail stores as the dominant channel of distribution for CBD nutraceuticals.

North America: The U.S. leads the North American CBD nutraceuticals market is expected to grow at 17.5% CAGR, to reach USD 25.7 billion by the end of 2034.
 

• The U.S. CBD nutraceuticals industry is the largest globally due to favorable regulations, high consumer awareness, and increasing acceptance of cannabis-derived products. The growing prevalence of chronic diseases including arthritis and anxiety disorders among the U.S. population has boosted the demand for CBD-based health solutions including nutraceuticals.
   
• The expansion of the market is supported by major players as well as extensive retail network. In addition, CBD products benefit from changing wellness and holistic healthcare trends. The market grows further due to the increasing availability of CBD food and drinks in retail stores and online shops.
   
• On the other hand, leading consumer states such as California and Colorado with advanced cannabis laws also strengthen the market through research innovations.
   

Europe: The Germany CBD nutraceuticals market is experiencing robust growth in Europe market.  
 

• Germany leads Europe’s CBD nutraceutical market due to its progressive regulations towards cannabis as well as the current use of nature-oriented health remedies.
   
• Germany's advanced healthcare infrastructure and focus on treatment options have increased interest in CBD products for managing chronic pain, stress, and insomnia.
   
• German pharmacies and wellness stores offer CBD products, thus improving overall access. Germany’s stringent quality requirements also greatly help German consumers. The market is strengthened by partnerships between local suppliers and foreign CBD companies.
   

Asia Pacific: The Asia Pacific CBD nutraceuticals market is growing at 17.8% during the analysis period, with China dominating the regional market share.
 

• China's traditional medicine market is growing, and people are more interested in wellness products. This is helping CBD nutraceutical products become more popular. While cannabis has many restrictions, CBD is legal in cosmetics and is now being used in nutraceutical products for health benefits.
   
• Chinese consumers are moving toward CBD supplements and oils as they want more plant-based ingredients. Local companies are making more CBD products in China to meet this growing demand.
   
• Online shopping websites and social media campaigns are helping more people learn about CBD products. The market's future growth depends on new regulations and how well people understand the health benefits of CBD.
   

Latin America: The Brazil CBD nutraceuticals market is experiencing robust growth in Latin America market.
 

• Brazil's CBD nutraceutical market is expanding, driven by recent regulatory reforms and growing consumer interest in alternative health products. The approval of medical cannabis products by Brazil's health regulatory agency (ANVISA) has helped support the use of CBD in wellness applications.
   
• The high prevalence of chronic diseases such as epilepsy, anxiety, and neuropathic pain conditions has increased the demand for CBD supplements and oils. The access to medicines, specialty stores, pharmacies, and e-commerce stores makes CBD and its derivatives more accessible to the consumer market.
   

Middle East and Africa: The Saudi Arabia CBD nutraceuticals market is witnessing substantial growth in Middle East and Africa.
 

• The CBD nutraceutical market is still in its initial stage in Saudi Arabia, but there is a positive expectation of growth owing to changing social norms and greater publicity of CBD health products. There are still strict laws on cannabis and drugs, but there is increasing acceptance for hemp-derived CBD without THC.
   
• Saudi consumers are increasingly preferring herbal medicine, natural and plant-based health products. The entry of new foreign brands into the market through deals with local distributors as well as online retailing is essential for market development.
   

CBD Nutraceuticals Market Share

The top 5 companies in the market account for ~65% of the market share, including Bluebird Botanicals, Charlotte's Web, CV Sciences, Diamond CBD, and Elixinol. These companies maintain dominance through product innovation, organic certifications, and strategic partnerships that meet the growing demand for wellness-focused CBD solutions.
 

Additionally, companies are expanding their portfolios with water-soluble CBD, nano-emulsification, and broad-spectrum formulations to enhance bioavailability and effectiveness. For example, Charlotte’s Web and Green Roads are known for creating full-spectrum CBD oils and gummies for consumers seeking holistic health benefits.
 

To stay competitive, firms are investing in research and development for new delivery systems, such as CBD capsules, soft gels, and topicals. They are also expanding into products for sleep, stress, and recovery. These improvements are helping the market grow and bringing new innovations.
 

CBD Nutraceuticals Market Companies

Major players operating in the CBD nutraceuticals industry are:

• Bluebird Botanicals
• Charlotte's Web
• CV Sciences
• Diamond CBD
• Elixinol
• ENDOCA
• Foria Wellness
• Garden of Life (Nestle)
• Green Roads
• Irwin Naturals
• Isodiol
• Medical Marijuana
• MEDTERRA
   
• Charlotte's Web offers premium full-spectrum CBD oils formulated for overall wellness. Their flagship Original Formula CBD Oil helps promote relaxation and supports recovery from stress or exercise-induced inflammation.
   
• Green Roads specializes in pharmacist-formulated CBD products, including their CBD Relax Bears, which are designed to provide stress relief with precisely measured dosages for consistent results.
   
• MEDTERRA focuses on THC-free CBD solutions, such as their CBD Sleep Capsules, which combine CBD with melatonin to support restful sleep and improve overall nighttime recovery.
   

CBD Nutraceuticals Industry News

• In February 2024, Green Roads launched its new CBD Puffs, expanding its product lineup in the CBD Nutraceuticals Industry with a convenient, flavorful format designed to support wellness and relaxation for consumers seeking alternative health solutions.
   
• In March 2023, CV Sciences launched a new line of THC-free gummies and softgels. This expansion strengthens their position in the market, offering consumers alternative, non-psychoactive options for wellness and health benefits.
   
• In July 2023, Irwin Naturals entered the California market with new cannabis tinctures, expanding its CBD nutraceutical product line. This launch strengthens the brand's presence in the growing market for CBD-based wellness and dietary supplements.
   

The CBD nutraceuticals market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• CBD oils
• CBD tinctures
• CBD capsules and softgels
• CBD gummies and chews
• Other product types

Market, By Application

• Pain management
• Anxiety and stress reduction
• Sleep disorders
• Mental health
• Other applications

Market, By Distribution Channel

• Retail stores
• Pharmacies
• E-commerce
• Other distribution channels

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• MEA
  • South Africa
  • Saudi Arabia
  • UAE